CHI Board of Directors
CHI Chairman
George A. Scangos, Ph.D.
Chief Executive Officer
Biogen Idec

CHI President and CEO
David L. Gollaher, Ph.D.
California Healthcare Institute
CHI Board of Director Committees
Chairman, Biopharmaceutical Sector Policy Committee
David E.I. Pyott
Chairman of the Board and CEO
Allergan
Chairman, CHI Audit Committee
Tracy T. Lefteroff
National Life Sciences Partner
PricewaterhouseCoopers
Chairman, CHI Finance Committee
Lawrence P. Guiheen
President, BioPharmaceuticals
Baxter BioScience
Chairman, CHI Membership Committee
Peter G. Milner, M.D., F.A.C.C.
President, Co-Founder and, Member Board of Directors ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc.
Chairman, CHI Nominating and Governance Committee
John C. Martin, Ph.D.
Chairman and CEO
Gilead Sciences
Chairman, Medical Technologies Sector Policy Committee
Robert B. Hance
President
Abbott Vascular
Chairman, Research & Education Sector Policy Committee
Susan M. Baxter, Ph.D.
Executive Director
California State University